Processing 00000000.tx.1: 7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A -Amyloid-induced Neurotoxicity* Takeshi Kihara, Shun Shimohama, Hideyuki Sawada, Kazuhiro Honda, Tomoki Nakamizo, Hiroshi Shibasaki, Toshiaki Kume, and Akinori Akaike From the Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507,Japan and the Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501,Japan Received for publication, September 1,2000, and in revised form, January 12,2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Multiple lines of evidence, from molecular and cellular to epidemiological, have implicated nicotinic transmission in the pathogenesis of Alzheimer's disease (AD). 

Phrase: "7 Nicotinic Receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Transduces"

Phrase: "Signals to Phosphatidylinositol 3-Kinase to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   805 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1710082:Signal [Phenomenon or Process]
   753   C2348046:Phosphatidylinositol [Lipid]

Phrase: "Block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "A -Amyloid-induced Neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "* Takeshi Kihara,"

Phrase: "Shun"

Phrase: "Shimohama,"

Phrase: "Hideyuki Sawada,"

Phrase: "Kazuhiro Honda,"

Phrase: "Tomoki Nakamizo,"

Phrase: "Hiroshi Shibasaki,"

Phrase: "Toshiaki Kume,"

Phrase: "and"

Phrase: "Akinori Akaike From the Department of Neurology,"

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Kyoto University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyoto 606-8507,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "the Department of Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "Kyoto University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyoto 606-8501,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 1,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "January 12,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Multiple lines of evidence,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "from molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "cellular to epidemiological,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0007634:Cellular [Cell]
   790   C0178539:Cellular [Functional Concept]
   718 E C1516377:Cellularity [Qualitative Concept]

Phrase: "have"

Phrase: "implicated"

Phrase: "nicotinic transmission in the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C0242781:transmission of disease [Pathologic Function]
           disease transmission
           Transmission
   744   C0040722:transmission [Idea or Concept]
   744   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.2: Here we show the signal transduction mechanism involved in nicotinic receptor-mediated protection against -amyloid-enhanced glutamate neurotoxicity. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the signal transduction mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C0037083:Signal Transduction [Cell Function]

Phrase: "involved in nicotinic receptor-mediated protection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1314939:Involved [Functional Concept]
   753   C1545588:Protection [Finding]

Phrase: "against -amyloid-enhanced glutamate neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.3: Nicotine-induced protection was suppressed by an 7 nicotinic receptor antagonist (-bungarotoxin), a phosphatidylinositol 3-kinase (PI3K) inhibitor (LY294002 and wortmannin), and a Src inhibitor (PP2). 

Phrase: "Nicotine-induced protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "suppressed by an 7 nicotinic receptor antagonist"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0242956:Nicotinic Receptor Antagonist [Pharmacologic Substance]
           Nicotinic Antagonist
   778   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0231491:Antagonist [Organ or Tissue Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1260953:Suppressed [Functional Concept]

Phrase: "(-bungarotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: ")"

Phrase: ","

Phrase: "a phosphatidylinositol 3-kinase (PI3K) inhibitor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   861   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   861   C3537023:kinase inhibitor [Molecular Function]
   861   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a Src inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(PP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.4: Levels of phosphorylated Akt, an effector of PI3K, and Bcl-2 were increased by nicotine. 

Phrase: "Levels of phosphorylated Akt,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "an effector of PI3K,"

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "were"

Phrase: "increased by nicotine."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.5: The 7 nicotinic receptor was physically associated with the PI3K p85 subunit and Fyn. 

Phrase: "The 7 nicotinic receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "physically"

Phrase: "associated with the PI3K p85 subunit"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3541313:p85 [Gene or Genome]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "Fyn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.6: These findings indicate that the 7 nicotinic receptor transduces signals to PI3K in a cascade, which ultimately contributes to a neuroprotective effect. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the 7 nicotinic receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "transduces"

Phrase: "signals to PI3K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "in a cascade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "which ultimately"

Phrase: "contributes to a neuroprotective effect."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0815279:Neuroprotective Effect [Functional Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.7: This might form the basis of a new treatment for AD.  

Phrase: "This"

Phrase: "might"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the basis of a new treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "for AD."
Processing 00000000.tx.8: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD)1 is one of the most common diseases presenting dementia. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "one of the most common diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.9: There are no definitive treatments or prophylactic agents for this neurodegenerative disease. 

Phrase: "There"

Phrase: "are"

Phrase: "no definitive treatments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C2986592:Definitive Treatment [Therapeutic or Preventive Procedure]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "prophylactic agents for this neurodegenerative disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.10: AD is characterized by the presence of two types of abnormal deposit, senile plaques and neurofibrillary tangles, and by extensive neuronal loss (1). 

Phrase: "AD"

Phrase: "is"

Phrase: "characterized by the presence of two types of abnormal deposit,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   777   C0332198:Abnormal presence of [Functional Concept]
           abnormal presence
   739   C0205161:Abnormal [Qualitative Concept]
   739   C0205448:Two [Quantitative Concept]
   739   C0332307:Types [Qualitative Concept]
   739   C0333562:Deposit [Functional Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1880022:Characterized [Activity]
   739   C2347472:% Abnormal [Quantitative Concept]
   739   C2699333:ABNORMAL [Intellectual Product]
   706 E C1547052:*Type [Quantitative Concept]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and by extensive neuronal loss"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0205231:Extensive [Qualitative Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1515981:And [Idea or Concept]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: -Amyloid (A) is a major constituent of senile plaques and one of the candidates for the cause of the neurodegeneration found in AD, because a negative correlation was found between senile plaques and neuron density (1). 

Phrase: "-Amyloid (A)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a major constituent of senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]

Phrase: "and"

Phrase: "one of the candidates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "for the cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "of the neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "found in AD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "because"

Phrase: "a negative correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "was"

Phrase: "found between senile plaques"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0150312:Found [Quantitative Concept]
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0243095:Find [Finding]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neuron density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: It has been hypothesized that accumulation of A precedes other pathological changes and causes neurodegeneration or neuronal death in vivo (2). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "that accumulation of A"

Phrase: "precedes"

Phrase: "other pathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Several mutations of the A precursor protein are found in familial AD, and these mutations are involved in amyloidogenesis (3). 

Phrase: "Several mutations of the A precursor protein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "found in familial AD,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0015576:familial [Family Group]
   770   C0150312:Found [Quantitative Concept]
   770   C0241888:Familial [Functional Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "involved in amyloidogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   790   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: It has also been shown that familial AD mutations of presenilin 1enhance the generation of A 1-42 (4). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that familial AD mutations of presenilin 1enhance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the generation of A 1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.15: However, presenilin 1transgenic mice do not have amyloid plaques in their brains, possibly because presenilin 1mutations facilitate apoptotic neuronal death without plaque formation (5). 

Phrase: "However,"

Phrase: "presenilin 1transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "amyloid plaques in their brains,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "because"

Phrase: "presenilin 1mutations"

Phrase: "facilitate"

Phrase: "apoptotic neuronal death without plaque formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C2754100:neuron death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: In addition, it is controversial whether A is directly toxic to neurons or not. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "whether"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "directly toxic to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "or"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.17: We have found that A 25-35 is toxic to neurons and that this cytotoxicity is inhibited by MK801, an N-methyl-D-aspartate receptor antagonist.2 Therefore, we hypothesized that A might modulate or enhance glutamate-induced cytotoxicity. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that A 25-35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "toxic to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "is"

Phrase: "inhibited by MK801,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "an N-methyl-"

Phrase: "D-"

Phrase: "aspartate receptor antagonist.2 Therefore,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   804   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0231491:Antagonist [Organ or Tissue Function]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   704 E C0680242:antagonism [Social Behavior]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "or"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glutamate-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.18: Glutamate, one of the excitotoxic neurotransmitters in the CNS, can cause intracellular Ca2+ influx, activation of Ca2+-dependent enzymes such as nitric oxide (NO) synthase, and production of toxic oxygen radicals leading to cell death (6). 

Phrase: "Glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "one of the excitotoxic neurotransmitters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in the CNS,"

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "intracellular Ca2+ influx,"

Phrase: "activation of Ca2+-dependent enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0014429:Enzyme Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "such as nitric oxide (NO) synthase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "production of toxic oxygen radicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "leading to cell death"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1522538:Leading [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.19: In addition, some reports have shown that A causes a reduction in glutamate uptake in cultured astrocytes (7), indicating that A-induced cytotoxicity might be mediated via glutamate cytotoxicity to some extent. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "some reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in glutamate uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in cultured astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that A-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "mediated via glutamate cytotoxicity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "to some extent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.20: In our previous reports, we showed that nicotinic acetylcholine receptor agonists exert a protective effect against glutamate- and A-induced neurotoxicity (8-12). 

Phrase: "In our previous reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that nicotinic acetylcholine receptor agonists"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   983   C0242948:Nicotinic Acetylcholine Receptor Agonist [Pharmacologic Substance]
           Nicotinic Receptor Agonist
           Nicotinic Agonists
   886 E C3536930:Nicotinic Agonist [Pharmacologic Substance]
   875   C0242894:Acetylcholine Agonists [Pharmacologic Substance]
   812   C0243192:agonists [Pharmacologic Substance]
   812   C2987634:agonists [Pharmacologic Substance]
   756   C0034830:Nicotinic Acetylcholine Receptor [Amino Acid, Peptide, or Protein,Receptor]
           Nicotinic Receptor
   756   C1749487:nicotinic acetylcholine receptor [Cell Component]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a protective effect against glutamate-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A-induced neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(8-12"

Phrase: ")."
Processing 00000000.tx.21: Recently, it has been reported that activated phosphatidylinositol 3-kinase (PI3K) and Akt kinase promote neuron survival (13). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that activated phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "Akt kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neuron survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.22: Anti-apoptotic proteins such as Bcl-2, Bcl-x, and Bad were thought to be involved in this survival system. 

Phrase: "Anti-apoptotic proteins such as Bcl-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Bcl-x,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332397:BCLX [Gene or Genome]
  1000   C1704960:BCLX [Gene or Genome]

Phrase: "and"

Phrase: "Bad"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "were"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in this survival system."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0449915:System involved [Spatial Concept]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0449913:System [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.23: Nicotinic receptors are ionotropic receptors, which allow Ca2+ to enter cells and function physiologically. 

Phrase: "Nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "ionotropic receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "which"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "Ca2+ to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "physiologically."
Processing 00000000.tx.24: It has been shown that the PI3K cascade is activated by tyrosine kinase or G protein-mediated signals in neuronal cells (14). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the PI3K cascade"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   812   C1707310:Cascade [Manufactured Object]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated by tyrosine kinase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "G protein-mediated signals in neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0037083:cell signals [Cell Function]
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.25: Conversely, there is no evidence that nicotinic receptors contain a G protein or tyrosine kinase. 

Phrase: "Conversely,"

Phrase: "there"

Phrase: "is"

Phrase: "no evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a G protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "tyrosine kinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.26: However, -amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors are also ionotropic receptors, and it was recently shown that a member of the Src family, Lyn, is physically associated with AMPA receptors and mediates signals to PI3K (15). 

Phrase: "However, -"

Phrase: "amino-3-hydroxy-5-methylisoxazole-4-propionic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   892   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   892   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0033482:propionic acid [Organic Chemical]
   812   C0072186:Propionic acid [Organic Chemical,Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]
   793   C2945750:propionic [Clinical Attribute]

Phrase: "(AMPA) receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0072899:AMPA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1819187:AMPA receptor [Cell Component]
   861   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "also ionotropic receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a member of the Src family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "Lyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "physically"

Phrase: "associated with AMPA receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0072899:AMPA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C1819187:AMPA receptor [Cell Component]
   770   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "signals to PI3K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.27: Thus, there is a possibility that ionotropic receptors such as nicotinic receptors could be associated with a tyrosine kinase such as Src. 

Phrase: "Thus,"

Phrase: "there"

Phrase: "is"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that ionotropic receptors such as nicotinic receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "be"

Phrase: "associated with a tyrosine kinase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as Src."
Processing 00000000.tx.28: In the present study, we showed that, at physiological concentrations, A itself is not neurotoxic but enhances the cell death induced by glutamate. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "at physiological concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself"

Phrase: "is"

Phrase: "not neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "but"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by glutamate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0205263:Induced [Functional Concept]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.29: The neuroprotective effect of nicotine was examined, focusing on the involvement of the PI3K cascade. 

Phrase: "The neuroprotective effect of nicotine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0815279:Neuroprotective Effect [Functional Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "focusing on the involvement of the PI3K cascade."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   782   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0000936:focusing [Clinical Attribute]
   739   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1314939:Involvement [Functional Concept]
   739   C1707310:Cascade [Manufactured Object]
   739   C2348046:Phosphatidylinositol [Lipid]
   739   C2981153:Focusing [Finding]
   706 E C0205234:Focus [Spatial Concept]
   706 E C1285542:focus [Functional Concept]
Processing 00000000.tx.30: In addition, we investigated whether nicotinic receptors function as metabotropic receptors through any kinase families.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "function as metabotropic receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0920644:function receptors [Molecular Function]
   816   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "through any kinase families."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.31: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- The sources of drugs and materials used in this study were as follows: Eagle's minimum essential medium (EMEM) (Nissui Pharmaceutical Co.); 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The sources of drugs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449416:sources [Finding]
   737 E C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Eagle's minimum essential medium (EMEM)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "(Nissui Pharmaceutical Co."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.32: -amyloid protein fragments 1-40, 1-42, 40-1, 42-1, 1-16, 12-28 and amyloid P component (27-38) (Bachem); 

Phrase: "-amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "1-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1-42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "40-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "42-1,"

Phrase: "1-16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "12-28"

Phrase: "and"

Phrase: "amyloid P component"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002721:Amyloid P Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(27-38"

Phrase: ")"

Phrase: "(Bachem"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.33: ()-nicotine, MK801, and monoclonal anti-7 nicotinic acetylcholine antibody (Research Biochemicals International); 

Phrase: "("

Phrase: ")-"

Phrase: "nicotine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "monoclonal anti-7 nicotinic acetylcholine antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Research Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205474:Biochemical [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.34: -bungarotoxin (Wako); 

Phrase: "-bungarotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "(Wako"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.35: LY294002 (Biomol Research Laboratories, Inc.); 

Phrase: "LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Biomol Research Laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.36: PP2 (Calbiochem); 

Phrase: "PP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.37: PD98059, anti-phospho- and nonphospho-specific p44/p42 mitogen-activated protein (MAP) kinase and Akt antibodies (New England Biolabs); 

Phrase: "PD98059,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "anti-phospho-"

Phrase: "and"

Phrase: "nonphospho-specific p44/p42 mitogen-activated protein (MAP) kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   835   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   812   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0026249:Mitogen [Pharmacologic Substance]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1879547:Activated [Activity]
   760 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "Akt antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.38: anti-microtubule-associated protein 2(MAP2) antibody (Sigma); 

Phrase: "anti-microtubule-associated protein 2"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   937   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   884   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026046:Micro-tubule [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(MAP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417006:MAP2 [Gene or Genome]
  1000   C1424480:MAP2 [Gene or Genome]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.39: polyclonal anti-Fyn antibody (Upstate Biotechnology Inc.); 

Phrase: "polyclonal anti-Fyn antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.40: polyclonal anti-PI3K p85 subunit antibody and anti-4 nicotinic acetylcholine antibody (Santa Cruz); 

Phrase: "polyclonal anti-PI3K p85 subunit antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   892   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   883   C1275482:Anti-phosphatidyl inositol antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Phosphatidyl inositol antibody
   878   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-4 nicotinic acetylcholine antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: monoclonal anti-PI3K p85 subunit antibody and anti-Bcl-2 antibody (Transduction Laboratories). 

Phrase: "monoclonal anti-PI3K p85 subunit antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   892   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   883   C1275482:Anti-phosphatidyl inositol antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Phosphatidyl inositol antibody
   878   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-Bcl-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.42: Cell Cultures-- Primary cultures were obtained from the cerebral cortex of fetal rats (17-19 days gestation) by procedures described previously (11, 16). 

Phrase: "Cell Cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Primary cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0010453:Cultures [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from the cerebral cortex of fetal rats"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   744   C0015965:Fetal [Embryonic Structure]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0521457:Fetal [Functional Concept]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C1301820:Obtained [Functional Concept]
   744   C2700441:Cortex [Plant]
   711 E C1706701:Obtain [Activity]

Phrase: "(17-19 days gestation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032961:Gestation [Organism Function]
   741 E C0439671:Gestational [Temporal Concept]

Phrase: ")"

Phrase: "by procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.43: Briefly, single cells dissociated from the cerebral cortex of fetal rats were plated out onto plastic coverslips placed in Falcon dishes. 

Phrase: "Briefly,"

Phrase: "single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "dissociated from the cerebral cortex of fetal rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   744   C0015965:Fetal [Embryonic Structure]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0521457:Fetal [Functional Concept]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "out onto plastic coverslips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032167:Plastic [Substance]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "placed in Falcon dishes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0325579:Falcon, NOS [Bird]
   737   C0020498:DISH [Disease or Syndrome]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.44: Cultures were incubated in EMEM supplemented with 10% fetal calf serum (1to 5days after plating out) or 10% horse serum (6to 12days after plating out), glutamine (2mM), glucose (total 11mM), NaHCO3 (24mM), and HEPES (10mM). 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated in EMEM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0205224:Essential [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(1to 5days after plating out"

Phrase: ")"

Phrase: "or"

Phrase: "10% horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1518416:Serum, Horse [Immunologic Factor]
   827   C0019944:Horse [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C0242616:Horse [Mammal]
   827   C1265527:Horse [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(6to 12days after plating out"

Phrase: ")"

Phrase: ","

Phrase: "glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(2mM"

Phrase: ")"

Phrase: ","

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(total 11mM"

Phrase: ")"

Phrase: ","

Phrase: "NaHCO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "(24mM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(10mM"

Phrase: ")."
Processing 00000000.tx.45: Cultures were maintained at 37C in a humidified atmosphere of 5% CO2. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "of 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.46: Only mature cultures (10to 14days in vitro) were used for the experiments. 

Phrase: "Only mature cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "(10to 14days"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "used for the experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.47: The animals were treated in accordance with the guidelines published in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "treated in accordance with the guidelines"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0162791:Guidelines [Intellectual Product]
   753   C0220845:guidelines [Intellectual Product]
   753   C0282423:guidelines [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "published in the National Institutes of Health Guide"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C0034037:Published [Occupational Activity]
   744   C0181090:Guide [Professional or Occupational Group]
   744   C0302614:Guide [Medical Device]
   744   C1704324:Published [Intellectual Product]
   744   C1706050:Guide [Manufactured Object]
   744   C3245503:national [Intellectual Product]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "for the Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use of Laboratory Animals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
Processing 00000000.tx.48: Treatment of the Cultures-- All experiments were carried out in EMEM at 37C. 

Phrase: "Treatment of the Cultures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in EMEM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0205224:Essential [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "at 37C."
Processing 00000000.tx.49: Cultured neurons were exposed to glutamate for 24h followed by incubation with EMEM for a further 24h. 

Phrase: "Cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "exposed to glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with EMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "for a further 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]
Processing 00000000.tx.50: A and nicotine were added to the medium before exposure to glutamate. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "added to the medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "before exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.51: Antagonists were simultaneously added with nicotine. 

Phrase: "Antagonists"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243076:antagonists [Chemical Viewed Functionally]
   966 E C0231491:Antagonist [Organ or Tissue Function]
   893 E C0680242:antagonism [Social Behavior]

Phrase: "were"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "added with nicotine."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]
Processing 00000000.tx.52: When cells were exposed to glutamate, other drugs were removed. 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to glutamate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "other drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.53: Assessment of Neurotoxicity-- The number of neurons was evaluated by immunostaining with anti-MAP2 antibody. 

Phrase: "Assessment of Neurotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1261322:Assessment [Health Care Activity]
   790   C1516048:Assessment [Activity]

Phrase: "-"

Phrase: "-"

Phrase: "The number of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated by immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "with anti-MAP2 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.54: Neurotoxicity in each experiment was defined as a reduction in the survival rate, which was expressed as percentage survival relative to the survival observed in control cultures. 

Phrase: "Neurotoxicity in each experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "was"

Phrase: "defined as a reduction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "in the survival rate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038954:Survival Rate [Quantitative Concept]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "expressed as percentage survival"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "relative to the survival"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1711356:Relative Survival [Quantitative Concept]
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "observed in control cultures."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0010453:Cultures [Idea or Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.55: Immunostaining was performed by the methods described previously (17), using the primary antibody (anti-MAP2 antibody (diluted 1:500)) for 24h. 

Phrase: "Immunostaining"

Phrase: "was"

Phrase: "performed by the methods"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-MAP2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: ")"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.56: At least 200neurons were counted in 10to 20randomly selected fields at 100(total magnification) in control cultures to determine the total number of neurons. 

Phrase: "At least 200neurons"

Phrase: "were"

Phrase: "counted in 10to 20randomly selected fields"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C1707391:Select [Activity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "at 100"

Phrase: "(total magnification"

Phrase: ")"

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the total number of neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.57: Preparation of Cell Extracts-- Semiconfluent cultures were exposed to each treatment and incubated at 37C for various time intervals. 

Phrase: "Preparation of Cell Extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0920433:cell preparation [Laboratory Procedure]
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "Semiconfluent cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to each treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for various time intervals."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   867   C0872291:Time Interval [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1272706:intervals [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.58: Subsequently, cells were lysed in a buffer consisting of 20mM Tris/HCl, pH 7.0,2mM EGTA, 25mM 2-glycerophosphate, 1% Triton X-100, 2mM dithiothreitol, 1mM vanadate, 1mM phenylmethylsulfonyl fluoride, and 1% aprotinin and centrifuged at 15,000g for 30min at 4C. 

Phrase: "Subsequently,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in a buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]

Phrase: "consisting of 20mM Tris/HCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "25mM 2-glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "2mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM vanadate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042305:Vanadate [Inorganic Chemical]

Phrase: "1mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "centrifuged at 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 30min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.59: The supernatants were used as the cell extracts. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used as the cell extracts."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1273517:used [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C2828366:Extract [Substance]
Processing 00000000.tx.60: Immunoblotting and Immunoprecipitation-- Protein samples in sodium dodecyl sulfate (SDS) buffer were loaded onto SDS-polyacrylamide gels. 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "--"

Phrase: "Protein samples in sodium dodecyl sulfate (SDS) buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C1318391:Sodium in sample [Laboratory or Test Result]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "loaded onto SDS-polyacrylamide gels."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   814   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   778   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   774   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1708715:Loaded [Activity]
   748   C3536965:SULFATE [Element, Ion, or Isotope]
   714 E C1382104:Gel [Substance]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.61: After electrophoresis, proteins were electrotransferred to a polyvinylidene difluoride membrane (Immobilon, Millipore). 

Phrase: "After electrophoresis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "electrotransferred to a polyvinylidene difluoride membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "(Immobilon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]

Phrase: "Millipore"

Phrase: ")."
Processing 00000000.tx.62: Membranes were incubated with either antibodies in 20mM Tris/HCl, pH 7.6,135mM NaCl, 0.1% Tween 20containing 5% nonfat dry milk. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with either antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in 20mM Tris/HCl,"

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "135mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Tween 20containing 5% nonfat dry milk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   793   C0026131:Milk [Body Substance]
   793   C0349374:Milk [Food]
   793   C0444318:Milk [Substance]
   793   C2825079:Milk [Food]
   737 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   737 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   721 E C0443260:Milky [Finding]
Processing 00000000.tx.63: Subsequently membranes were incubated with horseradish peroxidase-conjugated anti-rabbit antibody. 

Phrase: "Subsequently membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with horseradish peroxidase-conjugated anti-rabbit antibody."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0034493:Rabbit [Mammal]
   744   C0330510:Horseradish [Food]
   744   C0522529:Conjugated [Spatial Concept]
   744   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   744   C1110641:Horseradish [Plant]
   744   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   744   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.64: Immunoreactive bands were detected by LumiGLO (New England Biolabs, Inc., Beverly, MA). 

Phrase: "Immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected by LumiGLO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(New England Biolabs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "Inc.,"

Phrase: "Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.65: Protein samples were immunoprecipitated with antibodies (described above) and then incubated with protein G-Sepharose as described previously (18). 

Phrase: "Protein samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immunoprecipitated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(described above"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with protein G-Sepharose"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.66: Samples were then subjected to SDS-polyacrylamide gel electrophoresis followed by immunoblotting. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   909   C0600209:Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis [Laboratory Procedure,Research Activity]
   800   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1382104:Gel [Substance]
   744   C3536965:SULFATE [Element, Ion, or Isotope]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "followed by immunoblotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.67: Statistics-- Data are expressed as the percentage of surviving neurons relative to the number of neurons in control culture (vehicle only) and represent the meanS.E. 

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "--"

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the percentage of surviving neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0027882:Neurons [Cell]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   714   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "relative to the number of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in control culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "(vehicle only"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0348005:Vehicle [Manufactured Object]
   789 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.E."
Processing 00000000.tx.68: Statistical significance was determined using one-way analysis of variance followed by Scheffe's multiple comparisons test.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "followed by Scheffe's multiple comparisons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0439064:Multiple [Quantitative Concept]
   726   C1707455:Comparison [Activity]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]
Processing 00000000.tx.69: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Pretreatment of Neurons with A Enhances Glutamate Cytotoxicity-- Cortical neurons were incubated with A 1-40 (1nM) or A 1-42 (100pM) for 7days, which did not induce cell death. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Pretreatment of Neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "with A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Glutamate Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "--"

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated with A 1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1nM"

Phrase: ")"

Phrase: "or"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "for 7days,"

Phrase: "which"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.70: These are the concentrations of A in the cerebrospinal fluid of AD patients (19). 

Phrase: "These"

Phrase: "are"

Phrase: "the concentrations of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "of AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.71: Treatment with a low dose of glutamate (20M) alone did not significantly induce cell death (Fig. 1a). 

Phrase: "Treatment with a low dose of glutamate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1708745:Low-Dose Treatment [Research Activity]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(20M"

Phrase: ")"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.72: Simultaneous exposure to the same dose of A 1-40 and 1-42 followed by glutamate caused a significant reduction in the number of neuronal cells (Fig. 1a). 

Phrase: "Simultaneous exposure to the same dose of A 1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332157:Exposure to [Clinical Attribute]
           Exposure
   757   C2826651:Exposure Dose [Quantitative Concept]
   739   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "and"

Phrase: "1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "followed by glutamate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant reduction in the number of neuronal cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.73: These findings suggested that A itself is not neurotoxic at physiological concentrations but makes neurons vulnerable to excitatory amino acids. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself"

Phrase: "is"

Phrase: "not neurotoxic at physiological concentrations"

Phrase: "but"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "vulnerable to excitatory amino acids."
Processing 00000000.tx.74: View larger version (74K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.75: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.76: a, effects of -amyloid (Beta) on glutamate (Glu) neurotoxicity. 

Phrase: "a,"

Phrase: "effects of -amyloid (Beta"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "on glutamate (Glu) neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.77: Cultures were exposed to A 1-40 (1nM) and/or A 1-42 (100pM) for 7days followed by a 24-h incubation with 20M glutamate. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to A 1-40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: "and/or"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "for 7days"

Phrase: "followed by a 24-h incubation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with 20M glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.78: Neither peptide alone caused neuronal death. 

Phrase: "Neither peptide alone caused neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]
   804   C2754100:neuron death [Cell Function]
Processing 00000000.tx.79: Simultaneous application of A 1-40 and A 1-42 (Beta 1-40/1-42) did not cause neuronal death, but enhanced glutamate cytotoxicity. 

Phrase: "Simultaneous application of A 1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Beta 1-40/1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C0439509:/40 [Temporal Concept]
   804   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal death,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "but"

Phrase: "enhanced glutamate cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.80: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.81: *, p<0.01compared with glutamate alone. b, immunostained images showing A-enhanced glutamate neurotoxicity. 

Phrase: "*,"

Phrase: "p<0.01compared with glutamate alone. b,"

Phrase: "immunostained images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "A-enhanced glutamate neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.82: Panel A, control; 

Phrase: "Panel A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.83: panel B, 20M glutamate alone; 

Phrase: "panel B,"

Phrase: "20M glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.84: panel C, A 1-40 (1nM)+A 1-42 (100pM); 

Phrase: "panel C,"

Phrase: "A 1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0439509:/40 [Temporal Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: "+A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.85: panel D, A 1-40 (1nM)+A 1-42 (100pM)+glutamate (20M). 

Phrase: "panel D,"

Phrase: "A 1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0439509:/40 [Temporal Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: "+A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "+glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20M"

Phrase: ")."
Processing 00000000.tx.86: Bar=1104 m We investigated whether the effect on glutamate cytotoxicity depends upon the A structure. 

Phrase: "Bar=1104 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the effect on glutamate cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "depends upon the A structure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0678594:Structure [Spatial Concept]
   760   C0725813:depend [Medical Device]
Processing 00000000.tx.87: Scrambled A, A 40-1, or 42-1 did not enhance glutamate cytotoxicity, even when incubated simultaneously with other peptides including 1-40 or 1-42 (Fig. 2a). 

Phrase: "Scrambled A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A 40-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0439509:/40 [Temporal Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "42-1"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glutamate cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "even"

Phrase: "when"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "simultaneously with other peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0521115:simultaneously [Temporal Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.88: None of the peptides caused neuronal death when administered alone. 

Phrase: "None of the peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "when"

Phrase: "administered alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]
Processing 00000000.tx.89: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.90: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.91: a, effects of scrambled beta amyloid (Beta) on glutamate (Glu) neurotoxicity. 

Phrase: "a,"

Phrase: "effects of scrambled beta amyloid (Beta"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: "on glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.92: Cultures were exposed to A 1-40 (1nM), A 40-1 (1nM), A 1-42 (100pM), or A 42-1 (100pM) for 7days followed by a 24-h incubation with 20M glutamate. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to A 1-40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: ","

Phrase: "A 40-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0439509:/40 [Temporal Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: ","

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "A 42-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "for 7days"

Phrase: "followed by a 24-h incubation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with 20M glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.93: None of the peptides alone caused neuronal death. 

Phrase: "None of the peptides alone caused neuronal death."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007465:Cause of Death [Finding]
           Death Cause
   778   C0804771:Cause of death [Clinical Attribute]
   744   C0011065:Death [Organism Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0205171:Alone [Quantitative Concept]
   744   C0439044:alone [Finding]
   744   C0456148:None [Quantitative Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C0549184:None [Quantitative Concept]
   744   C0679994:alone [Group Attribute]
   744   C1306577:Death, NOS [Finding]
   735   C2754100:neuron death [Cell Function]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.94: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.95: *, p<0.01compared with glutamate alone. b, effects of other fragments of -amyloid (Beta) on glutamate (Glu) neurotoxicity. 

Phrase: "*,"

Phrase: "p<0.01compared with glutamate alone. b,"

Phrase: "effects of other fragments of -amyloid (Beta"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: "on glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.96: Cultures were exposed to A 1-40 (1nM), A 1-42 (100pM), A 1-16 (10nM), A 12-28 (10nM), or A 27-38 (10nM) for 7days followed by a 24-h incubation with 20M glutamate. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to A 1-40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: ","

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: ","

Phrase: "A 1-16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10nM"

Phrase: ")"

Phrase: ","

Phrase: "A 12-28"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10nM"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "A 27-38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10nM"

Phrase: ")"

Phrase: "for 7days"

Phrase: "followed by a 24-h incubation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with 20M glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: Combined administration of fragments was performed as shown in the figure. 

Phrase: "Combined administration of fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "shown in the figure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.98: None of the peptides alone caused neuronal death. 

Phrase: "None of the peptides alone caused neuronal death."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007465:Cause of Death [Finding]
           Death Cause
   778   C0804771:Cause of death [Clinical Attribute]
   744   C0011065:Death [Organism Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0205171:Alone [Quantitative Concept]
   744   C0439044:alone [Finding]
   744   C0456148:None [Quantitative Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C0549184:None [Quantitative Concept]
   744   C0679994:alone [Group Attribute]
   744   C1306577:Death, NOS [Finding]
   735   C2754100:neuron death [Cell Function]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.99: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.100: *, p<0.01compared with glutamate alone. 

Phrase: "*,"

Phrase: "p<0.01compared with glutamate"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.101: In addition, other fragments of A, such as A 1-16 (10nM), 12-28 (10nM), and the amyloid P component (27-38) (10nM), did not significantly reduce the number of viable neurons after exposure to glutamate (Fig. 2b). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "other fragments of A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "such as A 1-16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10nM"

Phrase: ")"

Phrase: ","

Phrase: "12-28"

Phrase: "(10nM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the amyloid P component"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002721:Amyloid P Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid P
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(27-38"

Phrase: ")"

Phrase: "(10nM"

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "the number of viable neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.102: None of the peptides caused neuronal death when administered alone (data not shown). 

Phrase: "None of the peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "when"

Phrase: "administered alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: Although A 1-16 enhanced glutamate cytotoxicity, this was not statistically significant. 

Phrase: "Although"

Phrase: "A 1-16 enhanced glutamate cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   727 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   727 E C1511636:cytotoxic [Functional Concept]

Phrase: "this"

Phrase: "was"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.104: Nicotine Protects Neurons from A-enhanced Glutamate Cytotoxicity-- We used the 1-40 and 1-42 fragments of A, because these fragments are found in the brains of AD patients and are the most potent combination for the enhancement of glutamate cytotoxicity. 

Phrase: "Nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "Protects"

Phrase: "Neurons from A-enhanced Glutamate Cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1-42 fragments of A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "because"

Phrase: "these fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "found in the brains of AD patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0150312:Found [Quantitative Concept]
   714 E C0243095:Find [Finding]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "are"

Phrase: "the most potent combination for the enhancement of glutamate cytotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205195:Combination [Qualitative Concept]
   739   C1947911:Combination [Physical Object]
Processing 00000000.tx.105: Cortical neurons were incubated with both A 1-40 (1nM) and A 1-42 (100pM) for 7days, which enhanced glutamate cytotoxicity. 

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated with both A 1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0439509:/40 [Temporal Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1nM"

Phrase: ")"

Phrase: "and"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "for 7days,"

Phrase: "which"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "glutamate cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.106: This effect was inhibited by MK801 when incubated with glutamate, indicating that the toxicity was mediated via N-methyl-D-aspartate receptors (Fig. 3). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited by MK801"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "when"

Phrase: "incubated with glutamate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "indicating"

Phrase: "that"

Phrase: "the toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "mediated via N-methyl-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "D-"

Phrase: "aspartate receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052536:aspartate receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.109: Effects of nicotine (Nic) on -amyloid (Beta)-enhanced glutamate (Glu) neurotoxicity. 

Phrase: "Effects of nicotine (Nic) on -amyloid (Beta"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: ")-"

Phrase: "enhanced glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.110: Cultures were exposed to A 1-40 (1nM) and A 1-42 (100pM) for 7days followed by a 24-h incubation with 20M glutamate. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to A 1-40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: "and"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100pM"

Phrase: ")"

Phrase: "for 7days"

Phrase: "followed by a 24-h incubation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with 20M glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.111: Toxicity caused by this treatment was inhibited by 1M MK801 (MK). 

Phrase: "Toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "caused by this treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "inhibited by 1M MK801 (MK)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0470296:1M [Quantitative Concept]
   770   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.112: Nicotine protected cells from A-enhanced glutamate neurotoxicity. 

Phrase: "Nicotine protected cells from A-enhanced glutamate neurotoxicity."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   714   C0524828:Cell Protection [Physiologic Function]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.113: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.114: *, p<0.01compared with glutamate alone; 

Phrase: "*,"

Phrase: "p<0.01compared with glutamate"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.115: **, p<0.01compared with glutamate+A. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.01compared with glutamate+A."
Processing 00000000.tx.116: Co-incubating the cultures with nicotine (0.5M, 7days) and A significantly reduced A-enhanced glutamate cytotoxicity (Fig. 3). 

Phrase: "Co-incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1439852:incubating [Laboratory Procedure]

Phrase: "the cultures with nicotine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0010453:Cultures [Idea or Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "(0.5M,"

Phrase: "7days"

Phrase: ")"

Phrase: "and"

Phrase: "A significantly reduced A-enhanced glutamate cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   724 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   724 E C1511636:cytotoxic [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: Previously, we reported that nicotine protects neurons from glutamate-induced cytotoxicity (8-10). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "protects"

Phrase: "neurons from glutamate-induced cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "(8-10"

Phrase: ")."
Processing 00000000.tx.118: Therefore, we hypothesized that the protective effect of nicotine against A-enhanced glutamate cytotoxicity depends upon its effect on glutamate toxicity. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the protective effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "against A-enhanced glutamate cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]

Phrase: "depends upon its effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0725813:depend [Medical Device]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on glutamate toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.119: PI3K Contributes to the Protective Effect of Nicotine against Glutamate-induced Cytotoxicity-- To investigate the mechanism of the protective effect of nicotine, we focused on the PI3K cascade because PI3K has been reported to protect cells from apoptosis through Akt activation (13). 

Phrase: "PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Contributes to the Protective Effect of Nicotine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C1280500:Effect [Qualitative Concept]
   748   C1880177:Contribute [Activity]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "against Glutamate-induced Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the mechanism of the protective effect of nicotine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "focused on the PI3K cascade"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   853   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   814   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   786 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205234:Focused [Spatial Concept]
   748   C1285542:focused [Functional Concept]
   748   C1707310:Cascade [Manufactured Object]
   748   C2348046:Phosphatidylinositol [Lipid]

Phrase: "because"

Phrase: "PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "cells from apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "through Akt activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.120: The glutamate toxicity model was adopted because a low concentration of A alone was not toxic or only enhanced glutamate toxicity. 

Phrase: "The glutamate toxicity model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "adopted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]

Phrase: "because"

Phrase: "a low concentration of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "not toxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600688:toxic [Injury or Poisoning]
   861   C1407029:Toxic [Qualitative Concept]

Phrase: "or"

Phrase: "only enhanced glutamate toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.121: Furthermore, we showed that nicotine did not directly affect the A conformation as described previously (20). 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the A conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.122: Prolonged exposure to glutamate (50M, 24h) induced cytotoxicity. 

Phrase: "Prolonged exposure to glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0439590:Prolonged [Temporal Concept]

Phrase: "(50M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")"

Phrase: "induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.123: Incubating the cultures with nicotine (10M) for 24h prior to glutamate exposure significantly reduced glutamate cytotoxicity. 

Phrase: "Incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "the cultures with nicotine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0010453:Cultures [Idea or Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "prior to glutamate exposure significantly reduced glutamate cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   727 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   727 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.124: Simultaneous application of either LY294002 (10M) or wortmannin (100nM), both PI3K inhibitors, with nicotine reduced the protective effect of nicotine against glutamate cytotoxicity. 

Phrase: "Simultaneous application of either LY294002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(100nM"

Phrase: ")"

Phrase: ","

Phrase: "both PI3K inhibitors,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   991   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   861   C1152564:Kinase Inhibitors [Molecular Function]
   844 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   844 E C3537023:kinase inhibitor [Molecular Function]
   844 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the protective effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "against glutamate cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.125: -Bungarotoxin (BTX, 1nM), an 7-selective nicotinic receptor antagonist, also blocked the protection, indicating that the 7 subtype of nicotinic receptors is involved in this effect (Figs. 4a and 5). 

Phrase: "-Bungarotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "(BTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "1nM"

Phrase: ")"

Phrase: ","

Phrase: "an 7-selective nicotinic receptor antagonist,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0242956:Nicotinic Receptor Antagonist [Pharmacologic Substance]
           Nicotinic Antagonist
   804   C0231491:Antagonist [Organ or Tissue Function]
   704 E C0680242:antagonism [Social Behavior]

Phrase: "also"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the protection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "indicating"

Phrase: "that"

Phrase: "the 7 subtype of nicotinic receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449560:Subtype [Classification]

Phrase: "is"

Phrase: "involved in this effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(Figs. 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.127: 4.  

Phrase: "4."
Processing 00000000.tx.128: a, effect of nicotine on glutamate-induced cytotoxicity. 

Phrase: "a,"

Phrase: "effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on glutamate-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.129: Cultures were exposed to glutamate (50M) for 24h followed by incubation in EMEM for 24h, which induced cell death. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "exposed to glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(50M"

Phrase: ")"

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in EMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "which"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.130: Nicotine (1M) was preincubated with the cultures for 24h. 

Phrase: "Nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "preincubated with the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0010453:Cultures [Idea or Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.131: If used, LY294002 (LY), wortmannin (Wort), -bungarotoxin (BTX), PP2, cycloheximide (Cyclo), and PD98059 (PD) were added to the medium containing nicotine. 

Phrase: "If"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "LY294002 (LY),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "wortmannin (Wort), -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "bungarotoxin (BTX),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "PP2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "cycloheximide (Cyclo),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "PD98059 (PD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "added to the medium containing nicotine."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.132: After the preincubation, medium was replaced by glutamate-containing medium for 24h and finally replaced with EMEM, as described above. 

Phrase: "After the preincubation,"

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced by glutamate-containing medium"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C1299987:Replaced by [Functional Concept]
           replaced
   760   C0009458:Medium [Intellectual Product]
   760   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   760   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332256:Containing [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2700400:Containing [Activity]
   760   C3244283:medium [Intellectual Product]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "replaced with EMEM,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0205224:Essential [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.133: LY294002, wortmannin, and PI3K inhibitors all significantly reduced the protective effect of nicotine. 

Phrase: "LY294002,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "PI3K inhibitors"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   991   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   861   C1152564:Kinase Inhibitors [Molecular Function]
   844 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   844 E C3537023:kinase inhibitor [Molecular Function]
   844 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "all significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the protective effect of nicotine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.134: Furthermore, PP2, a Src family tyrosine kinase inhibitor, also reduced the protective effect of nicotine. 

Phrase: "Furthermore,"

Phrase: "PP2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "a Src family tyrosine kinase inhibitor,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C0282625:SRC Family Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           src Tyrosine Kinases
           src-Family Kinases
           src Kinases
   884   C1268567:Tyrosine Kinase Inhibitor [Pharmacologic Substance]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   840   C3537023:kinase inhibitor [Molecular Function]
   840   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "also"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the protective effect of nicotine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.135: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.136: *, p<0.01compared with glutamate alone; 

Phrase: "*,"

Phrase: "p<0.01compared with glutamate"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.137: **, p<0.01compared with glutamate+nicotine. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.01compared with glutamate+nicotine."
Processing 00000000.tx.138: NS, not significant. b, effect of DMXB on glutamate-induced cytotoxicity. 

Phrase: "NS,"

Phrase: "not significant. b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1273937:Not significant [Finding]

Phrase: "effect of DMXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on glutamate-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.139: DMXB (10M) was added to the medium and incubated for 24h. 

Phrase: "DMXB"

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "added to the medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 24h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]
Processing 00000000.tx.140: LY294002 significantly reduced the protective effect. 

Phrase: "LY294002 significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the protective effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.141: n=4; 

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.142: *, p<0.05compared with glutamate alone; 

Phrase: "*,"

Phrase: "p<0.05compared with glutamate"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.143: **, p<0.05compared with glutamate+nicotine. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.05compared with glutamate+nicotine."
Processing 00000000.tx.144: 3-(2,4)-Dimethoxybenzylidene anabaseine (DMXB, 10M), an 7-selective nicotinic receptor agonist (21), also exerted a protective effect against glutamate-induced cytotoxicity. 

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: ")-"

Phrase: "Dimethoxybenzylidene anabaseine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0293641:anabaseine [Organic Chemical]

Phrase: "(DMXB,"

Phrase: "10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "an 7-selective nicotinic receptor agonist"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0242948:Nicotinic Receptor Agonist [Pharmacologic Substance]
           Nicotinic Agonist
   853   C3536930:Nicotinic Agonist [Pharmacologic Substance]
   804   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "a protective effect against glutamate-induced cytotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.145: This effect was inhibited by 1nM BTX, indicating that the effect of DMXB is mediated via 7 receptors. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited by 1nM BTX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]
   770   C0311403:Inhibited [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the effect of DMXB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated via 7 receptors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.146: Furthermore, the protection was also reduced by 10M LY294002 (Fig. 4b). 

Phrase: "Furthermore,"

Phrase: "the protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "also"

Phrase: "reduced by 10M LY294002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1442446:10M [Temporal Concept]

Phrase: "(Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: From these findings, we concluded that 7 nicotinic receptor stimulation exerts a neuroprotective effect against glutamate cytotoxicity and that the PI3K cascade is involved in this effect. 

Phrase: "From these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that 7 nicotinic receptor stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a neuroprotective effect against glutamate cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0815279:Neuroprotective Effect [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the PI3K cascade"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   812   C1707310:Cascade [Manufactured Object]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "involved in this effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.148: We previously showed that 42 subunit nicotinic receptor stimulation also exerted a protective effect against A- and glutamate-induced cytotoxicity (10, 12). 

Phrase: "We previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 42 subunit nicotinic receptor stimulation also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   799   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "a protective effect against A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "glutamate-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "(10,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.149: This effect, however, was not inhibited by LY294002 (data not shown). 

Phrase: "This effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "however,"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by LY294002"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: View larger version (118K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.151: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.152: Immunostained images showing the protective effect of nicotine against glutamate neurotoxicity. 

Phrase: "Immunostained images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the protective effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "against glutamate neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.153: A, control; 

Phrase: "A,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.154: B, 50M glutamate alone; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "50M glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.155: C, nicotine (10M)+glutamate; 

Phrase: "C,"

Phrase: "nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "+glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.156: D, nicotine+LY294002 (10M)+glutamate; 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "nicotine+LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "+glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.157: E, nicotine+BTX (1nM)+glutamate; 

Phrase: "E,"

Phrase: "nicotine+BTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "(1nM"

Phrase: ")"

Phrase: "+glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.158: F, nicotine+PD98059 (50M)+glutamate. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "nicotine+PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "(50M"

Phrase: ")"

Phrase: "+glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: Bar=1104 m Furthermore, a non-receptor tyrosine kinase inhibitor, PP2 (10M), also reduced the protective effect. 

Phrase: "Bar=1104 m Furthermore,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "a non-receptor tyrosine kinase inhibitor,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   884   C1268567:Tyrosine Kinase Inhibitor [Pharmacologic Substance]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   840   C3537023:kinase inhibitor [Molecular Function]
   840   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "PP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the protective effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.160: This implies that Src is involved in the mechanism of protection. 

Phrase: "This"

Phrase: "implies"

Phrase: "that Src"

Phrase: "is"

Phrase: "involved in the mechanism of protection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441712:Mechanism [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1545588:Protection [Finding]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.161: Cycloheximide (1mg/ml) inhibited the protection, implying that some protein synthesis is necessary. 

Phrase: "Cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(1mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the protection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "implying"

Phrase: "that"

Phrase: "some protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "necessary."
Processing 00000000.tx.162: In contrast, PD98059 (50M), a mitogen-activated protein kinase (MAPK) kinase (MAPKK, also known as MEK1) inhibitor, did not reduce the protective effect of nicotine (Figs. 4a and 5). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "(50M"

Phrase: ")"

Phrase: ","

Phrase: "a mitogen-activated protein kinase (MAPK) kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   958   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(MAPKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0169101:MAPKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150604:MAPKK [Molecular Function]

Phrase: "also"

Phrase: "known as MEK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205309:Known [Qualitative Concept]
   790   C1150604:MEK1 [Molecular Function]
   790   C1334474:MEK1 [Gene or Genome]
   790   C1708799:MEK1 [Gene or Genome]

Phrase: ")"

Phrase: "inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "the protective effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(Figs. 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.163: Nicotine Activates Akt through PI3K Activation and Up-regulates Bcl-2-- Akt is a serine/threonine protein kinase and a putative effector of PI3K. 

Phrase: "Nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "Activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt through PI3K Activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "Up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "--"

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "is"

Phrase: "a serine/threonine protein kinase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0072402:Serine-Threonine Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine-Threonine Kinase
           Serine Kinase
           Threonine Kinase
  1000   C1335197:serine/threonine-protein kinase [Gene or Genome]
  1000   C1367673:serine/threonine protein-kinase [Gene or Genome]
   923   C1414387:serine/threonine kinase [Gene or Genome]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "a putative effector of PI3K."
Processing 00000000.tx.164: When PI3K is activated, it phosphorylates Akt. 

Phrase: "When"

Phrase: "PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "it"

Phrase: "phosphorylates"

Phrase: "Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.165: To investigate the activation of Akt by nicotine through PI3K, we examined the level of phosphorylated Akt detected by an antibody specific for phospho-Akt using Western blotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the activation of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "through PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the level of phosphorylated Akt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "detected by an antibody specific"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1552740:specific [Intellectual Product]
   735 E C0003264:Antibody Specificity [Molecular Function]

Phrase: "for phospho-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.166: In preliminary experiments, phosphorylation of Akt was detected just after the application of nicotine. 

Phrase: "In preliminary experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "just after the application of nicotine."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.167: The levels of phosphorylated Akt increased and reached a plateau after around 60-min stimulation and were maintained for 24h (data not shown). 

Phrase: "The levels of phosphorylated Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a plateau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "after around 60-min stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0231290:After [Temporal Concept]
   760   C0687676:After [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "were"

Phrase: "maintained for 24h"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1314677:Maintained [Functional Concept]
   790   C1442770:24H [Temporal Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: Therefore, 60-min stimulation was adopted for the following experiments. 

Phrase: "Therefore,"

Phrase: "60-min stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "adopted for the following experiments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0425382:Adopted [Finding]
   760   C0681814:Experiments [Research Activity]
   726   C0332283:follow [Temporal Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.169: Nicotine-induced Akt phosphorylation was blocked by the simultaneous application of LY294002, showing the involvement of PI3K (Fig. 6a). 

Phrase: "Nicotine-induced Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "blocked by the simultaneous application of LY294002,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0028778:Blocked [Pathologic Function]
   748   C0185125:Application [Health Care Activity]
   748   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   748   C0332206:Blocked [Functional Concept]
   748   C0521115:Simultaneous [Temporal Concept]
   748   C1548968:Simultaneous [Idea or Concept]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C2983591:BLOCKED [Research Activity]
   748   C3539080:APPLICATION [Quantitative Concept]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the involvement of PI3K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "(Fig. 6a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.170: PD98059 did not alter the phosphorylating effect of nicotine. 

Phrase: "PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the phosphorylating effect of nicotine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.171: Akt phosphorylation was blocked by BTX, indicating that the phosphorylating effect of nicotine is mediated by 7 nicotinic receptors (Fig. 6, b and c). 

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "blocked by BTX,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the phosphorylating effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by 7 nicotinic receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.172: Conversely, dihydro--erythroidine (100nM), a selective 42 nicotinic receptor antagonist, did not block nicotine-induced Akt phosphorylation (Fig. 6c). 

Phrase: "Conversely,"

Phrase: "dihydro"

Phrase: "--"

Phrase: "erythroidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178624:erythroidine [Organic Chemical,Pharmacologic Substance]

Phrase: "(100nM"

Phrase: ")"

Phrase: ","

Phrase: "a selective 42 nicotinic receptor antagonist,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0242956:Nicotinic Receptor Antagonist [Pharmacologic Substance]
           Nicotinic Antagonist
   804   C0231491:Antagonist [Organ or Tissue Function]
   704 E C0680242:antagonism [Social Behavior]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "nicotine-induced Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 6c"

Phrase: ")."
Processing 00000000.tx.173: PP2 blocked Akt phosphorylation, indicating the involvement of tyrosine kinase. 

Phrase: "PP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "Akt phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "indicating"

Phrase: "the involvement of tyrosine kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.174: 10M MK801 did not block Akt phosphorylation, showing that the secondary release of glutamate has no effect (Fig. 6b). 

Phrase: "10M MK801"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "Akt phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the secondary release of glutamate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 6b"

Phrase: ")."
Processing 00000000.tx.175: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 6.  

Phrase: "6."
Processing 00000000.tx.177: Representative data of phosphorylation of Akt/PKB by nicotine detected by Western blot using antibody specific for phosphorylated Akt. a, nicotine (Nic, 10M) increased the levels of the phosphorylated Akt compared with the total Akt levels. 

Phrase: "Representative data of phosphorylation of Akt/PKB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "by nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "detected by Western blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody specific for phosphorylated Akt."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   735 E C0003264:Antibody Specificity [Molecular Function]

Phrase: "a,"

Phrase: "nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Nic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the levels of the phosphorylated Akt"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with the total Akt levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0812228:AKT [Gene or Genome]
   753   C1707455:Compared [Activity]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.178: This phosphorylation was significantly inhibited by LY294002 (10M). 

Phrase: "This phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "inhibited by LY294002"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.179: PD98059 (50M), a MEK1 inhibitor, did not interfere with Akt phosphorylation. 

Phrase: "PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "(50M"

Phrase: ")"

Phrase: ","

Phrase: "a MEK1 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with Akt phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0812228:AKT [Gene or Genome]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.180: Each inhibitor was added simultaneously with glutamate. 

Phrase: "Each inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "simultaneously with glutamate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.181: PD, PD98059; 

Phrase: "PD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.182: LY, LY294002. 

Phrase: "LY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "LY294002."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.183: n=6.b, Akt phosphorylation was inhibited by BTX (1nM) and PP2 (10M), a Src inhibitor. 

Phrase: "n=6.b,"

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "inhibited by BTX"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(1nM"

Phrase: ")"

Phrase: "and"

Phrase: "PP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417819:PP2 [Gene or Genome]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "a Src inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.184: MK801 (10M) did not reduce the phosphorylation of Akt induced by nicotine. 

Phrase: "MK801"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "induced by nicotine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.185: BTX, BTX; 

Phrase: "BTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "BTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: ";"
Processing 00000000.tx.186: MK, MK801. 

Phrase: "MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "MK801."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.187: n=6.c, Akt phosphorylation was not inhibited by dihydro--erythroidine (100nM) in contrast to BTX. 

Phrase: "n=6.c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C2349138:N/C [Quantitative Concept]

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by dihydro"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "--"

Phrase: "erythroidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178624:erythroidine [Organic Chemical,Pharmacologic Substance]

Phrase: "(100nM"

Phrase: ")"

Phrase: "in contrast to BTX."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]
Processing 00000000.tx.188: BTX, BTX. 

Phrase: "BTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "BTX."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]
Processing 00000000.tx.189: n=6.d, Bcl-2 was up-regulated after nicotine treatment. 

Phrase: "n=6.d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1513911:N.D. [Intellectual Product]

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "was"

Phrase: "up-regulated after nicotine treatment."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.190: LY294002 (10M) inhibited the up-regulation of Bcl-2, indicating that nicotine-induced up-regulation of Bcl-2 is mediated via the PI3K cascade. 

Phrase: "LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the up-regulation of Bcl-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "indicating"

Phrase: "that nicotine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "up-regulation of Bcl-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "mediated via the PI3K cascade."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   853   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   814   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   786 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C1707310:Cascade [Manufactured Object]
   748   C2348046:Phosphatidylinositol [Lipid]
Processing 00000000.tx.191: n=6. 

Phrase: "n=6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.192: Bcl-2 proteins are anti-apoptotic proteins, which can prevent cell death induced by a variety of toxic insults (22). 

Phrase: "Bcl-2 proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "are"

Phrase: "anti-apoptotic proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by a variety of toxic insults"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205263:Induced [Functional Concept]
   748   C0600688:toxic [Injury or Poisoning]
   748   C1407029:Toxic [Qualitative Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.193: It has been reported that Akt activation leads to the overexpression of Bcl-2 (23). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that Akt activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "leads to the overexpression of Bcl-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0376515:Bcl-2 [Gene or Genome]
   774   C2346661:Lead 2+ [Element, Ion, or Isotope]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1514559:Overexpression [Genetic Function]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.194: Because nicotine could activate Akt via PI3K, we examined the protein levels of Bcl-2. 

Phrase: "Because"

Phrase: "nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt via PI3K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the protein levels of Bcl-2."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   820   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0456948:Level 2 [Intellectual Product]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.195: Treatment with nicotine for 24h induced the augmented level of Bcl-2, and the nicotine-induced up-regulation of Bcl-2 was reduced by LY294002, indicating the involvement of PI3K signal transduction (Fig. 6d). 

Phrase: "Treatment with nicotine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the augmented level of Bcl-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the nicotine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "up-regulation of Bcl-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "was"

Phrase: "reduced by LY294002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "indicating"

Phrase: "the involvement of PI3K signal transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1314939:Involvement [Functional Concept]

Phrase: "(Fig. 6d"

Phrase: ")."
Processing 00000000.tx.196: 7 Nicotinic Acetylcholine Receptors Physically Associate with PI3K and Fyn-- The present results show that nicotine protects neurons from glutamate cytotoxicity by activating PI3K, which activates Akt and up-regulates Bcl-2. 

Phrase: "7 Nicotinic Acetylcholine Receptors Physically"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0034830:Nicotinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Nicotinic Receptors
   851 E C1749487:nicotinic acetylcholine receptor [Cell Component]
   840   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   804   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Associate with PI3K"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   834 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C2348046:Phosphatidylinositol [Lipid]

Phrase: "and"

Phrase: "Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "-"

Phrase: "-"

Phrase: "The present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "protects"

Phrase: "neurons from glutamate cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "by activating PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "Bcl-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.197: Nicotinic receptors are ionotropic, and there have been no reports of ionotropic receptors activating PI3K directly. 

Phrase: "Nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "ionotropic,"

Phrase: "and"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "no reports of ionotropic receptors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0684224:Reports [Intellectual Product]
   760   C0700287:reports [Health Care Activity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "PI3K directly."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.198: Therefore, we hypothesized that nicotinic receptors may act as metabotropic receptors, directly transmitting signals to PI3K. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "act as metabotropic receptors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "directly transmitting signals to PI3K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.199: In other words, nicotinic receptors might associate with PI3K. 

Phrase: "In other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "might"

Phrase: "associate with PI3K."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   834 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C2348046:Phosphatidylinositol [Lipid]
Processing 00000000.tx.200: To demonstrate this, lysates of cortical neurons were immunoprecipitated with a monoclonal anti-7 nicotinic receptor antibody. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "this,"

Phrase: "lysates of cortical neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "immunoprecipitated with a monoclonal anti-7 nicotinic receptor antibody."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   764   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0746619:monoclonal [Finding]
   708   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.201: Immunoprecipitated (IP) samples were then separated by SDS-polyacrylamide gel electrophoresis and stained with a polyclonal anti-PI3K p85 subunit antibody using the Western blot technique. 

Phrase: "Immunoprecipitated (IP) samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separated by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   909   C0600209:Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis [Laboratory Procedure,Research Activity]
   800   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0687118:Separated [Functional Concept]
   744   C1382104:Gel [Substance]
   744   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "stained with a polyclonal anti-PI3K p85 subunit antibody"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   775   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772   C1275482:Anti-phosphatidyl inositol antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Phosphatidyl inositol antibody
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1711351:Subunit [Quantitative Concept]
   738   C2348046:Phosphatidylinositol [Lipid]
   738   C2986582:Stained [Qualitative Concept]
   738   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C3541313:p85 [Gene or Genome]
   704 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Western blot technique."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0949466:Western Blot [Laboratory Procedure]
   827   C0449851:Technique [Functional Concept]
   827   C1705493:Western [Spatial Concept]
   743 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.202: The PI3K p85 subunit was detected in this IP sample, indicating that 7 nicotinic receptors bind to the PI3K p85 subunit (Fig. 7a). 

Phrase: "The PI3K p85 subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1711351:Subunit [Quantitative Concept]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "detected in this IP sample,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0370003:Sample [Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2347026:Sample [Conceptual Entity]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "indicating"

Phrase: "that 7 nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "bind to the PI3K p85 subunit"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3541313:p85 [Gene or Genome]

Phrase: "(Fig. 7a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.203: Conversely, lysate immunoprecipitated with the polyclonal anti PI3K p85 subunit antibody contained protein detected by the monoclonal anti-7 nicotinic receptor antibody. 

Phrase: "Conversely,"

Phrase: "lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "immunoprecipitated with the polyclonal anti PI3K p85 subunit antibody"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   775   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772   C1275482:Anti-phosphatidyl inositol antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Phosphatidyl inositol antibody
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1711351:Subunit [Quantitative Concept]
   738   C2348046:Phosphatidylinositol [Lipid]
   738   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C3541313:p85 [Gene or Genome]
   704   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected by the monoclonal anti-7 nicotinic receptor antibody."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   764   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0442726:Detected [Finding]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0746619:monoclonal [Finding]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: Non-receptor type tyrosine kinase, Fyn, was also co-immunoprecipitated with the 7 nicotinic receptors (Fig. 7b). 

Phrase: "Non-receptor type tyrosine kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Fyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "co-immunoprecipitated with the 7 nicotinic receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 7b"

Phrase: ")."
Processing 00000000.tx.205: The 4subunit of the nicotinic receptor was also investigated and was not detected in lysates immunoprecipitated with the PI3K p85 subunit, Fyn, or the 7 nicotinic receptor antibody (Fig. 7c). 

Phrase: "The 4subunit of the nicotinic receptor"

Phrase: "was"

Phrase: "also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C1881488:Lysate [Physical Object]

Phrase: "immunoprecipitated with the PI3K p85 subunit,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3541313:p85 [Gene or Genome]
   711   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "Fyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "the 7 nicotinic receptor antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 7c"

Phrase: ")."
Processing 00000000.tx.206: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 7.  

Phrase: "7."
Processing 00000000.tx.208: Association of the 7 nicotinic receptor with PI3K and Fyn. a, the PI3K was detected in IP produced using the anti-7 nicotinic receptor antibody (left). 

Phrase: "Association of the 7 nicotinic receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Fyn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a,"

Phrase: "the PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "detected in IP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-7 nicotinic receptor antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.209: Conversely, the 7 nicotinic receptor was detected in IP produced using the anti-p85 subunit PI3K antibody (right). 

Phrase: "Conversely,"

Phrase: "the 7 nicotinic receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "detected in IP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-p85 subunit PI3K antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C1275482:Anti-phosphatidyl inositol antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Phosphatidyl inositol antibody
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.210: n=6.nAChR, nicotinic acetylcholine receptor. b, Fyn was detected in IP produced using the anti-7 nicotinic receptor antibody. 

Phrase: "n=6.nAChR,"

Phrase: "nicotinic acetylcholine receptor. b,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0034830:Nicotinic Acetylcholine Receptor [Amino Acid, Peptide, or Protein,Receptor]
           Nicotinic Receptor
   756   C1749487:nicotinic acetylcholine receptor [Cell Component]

Phrase: "Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "detected in IP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-7 nicotinic receptor antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.211: Conversely, 7 nicotinic receptors were detected in IP produced using the anti-Fyn antibody (right). 

Phrase: "Conversely,"

Phrase: "7 nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "detected in IP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-Fyn antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.212: n=6.c, the 4 subunit of the nicotinic receptor was not detected in any of the IP samples produced using the anti-PI3K p85 subunit, Fyn, or the 7 nicotinic receptor antibody.  

Phrase: "n=6.c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C2349138:N/C [Quantitative Concept]

Phrase: "the 4 subunit of the nicotinic receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in any of the IP samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-PI3K p85 subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1711351:Subunit [Quantitative Concept]

Phrase: "Fyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "the 7 nicotinic receptor antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.213: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES There is still a controversy about the role of A and glutamate in the pathogenesis of AD. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES There"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1514811:Reference [Idea or Concept]
   756   C1706462:Reference [Conceptual Entity]

Phrase: "is"

Phrase: "still"

Phrase: "a controversy about the role of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680243:controversy [Social Behavior]

Phrase: "and"

Phrase: "glutamate in the pathogenesis of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.214: However, amyloid accumulation is one of the earliest changes in AD pathology, and this peptide may cause neuronal death in the central nervous system (2). 

Phrase: "However,"

Phrase: "amyloid accumulation"

Phrase: "is"

Phrase: "one of the earliest changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in AD pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "this peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal death in the central nervous system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]
   743   C2754100:neuron death [Cell Function]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.215: The precise mechanism of A-induced cytotoxicity remains unknown, although various hypotheses have been suggested. 

Phrase: "The precise mechanism of A-induced cytotoxicity remains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "although"

Phrase: "various hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "suggested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]
Processing 00000000.tx.216: Oxidative stress, or free radical generation, is one of the candidates for the cause of A-induced cytotoxicity. 

Phrase: "Oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "or"

Phrase: "free radical generation,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "one of the candidates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "for the cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "of A-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.217: Previous reports have shown that A stimulates NO production through Ca2+ entry triggered by activated N-methyl-D-aspartate-gated channels (24). 

Phrase: "Previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "NO production through Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "triggered by activated N-methyl-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   760   C1879547:Activated [Activity]
   726   C0032930:Trigger [Clinical Attribute]
   726 E C1515877:Activate [Functional Concept]

Phrase: "D-"

Phrase: "aspartate-gated channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.218: Other reports have suggested that A inhibits glutamate uptake and causes extracellular glutamate increase (7). 

Phrase: "Other reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glutamate uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "extracellular glutamate increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.219: There are also some reports that have proposed that A enhances the toxicity induced by excitotoxins (25, 26). 

Phrase: "There"

Phrase: "are"

Phrase: "also"

Phrase: "some"

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "have"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "induced by excitotoxins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0935931:Excitotoxins [Hazardous or Poisonous Substance]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.220: These reports implied that A-induced cytotoxicity might be, at least in part, mediated via glutamate toxicity. 

Phrase: "These reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "implied"

Phrase: "that A-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "mediated via glutamate toxicity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.221: The present study also indicated that A enhances glutamate neurotoxicity. 

Phrase: "The present study also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glutamate neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.222: The present data show that only a combination of A 1-40 and A 1-42 enhanced glutamate cytotoxicity. 

Phrase: "The present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a combination of A 1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "A 1-42 enhanced glutamate cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   727 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   727 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.223: The concentration of these peptides used in this study were almost the same level as that detected in the cerebrospinal fluid of AD patients (19). 

Phrase: "The concentration of these peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "almost"

Phrase: "the same level as that"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "detected in the cerebrospinal fluid of AD patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0007806:Cerebrospinal Fluid [Body Substance]
   770   C0007807:cerebrospinal fluid [Functional Concept]
   744   C0005889:FLUID [Body Substance]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0302908:fluid [Substance]
   744   C0442726:Detected [Finding]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1704353:Fluid [Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.224: Other fragments did not enhance the toxicity, even when administered simultaneously with A 1-40 or A 1-42. 

Phrase: "Other fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "even"

Phrase: "when"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "simultaneously with A 1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439509:/40 [Temporal Concept]
   760   C0521115:simultaneously [Temporal Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "A 1-42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.225: Therefore, the enhancing effect appears to be related to the structure of the peptides so that the combination of A 1-40 and A 1-42 might play a specific role in making neurons vulnerable to glutamate. 

Phrase: "Therefore,"

Phrase: "the enhancing effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "related to the structure of the peptides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C0597196:peptide structure [Spatial Concept]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0678594:Structure [Spatial Concept]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the combination of A 1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a specific role in making neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "vulnerable to glutamate."
Processing 00000000.tx.226: The full length of both peptides appears to be necessary. 

Phrase: "The full length of both peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443225:Full [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "necessary."
Processing 00000000.tx.227: We previously showed that nicotinic receptor stimulation protects neurons from A- and glutamate-induced cell death (8-12). 

Phrase: "We previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that nicotinic receptor stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "protects"

Phrase: "neurons from A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glutamate-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(8-12"

Phrase: ")."
Processing 00000000.tx.228: In the present study, we showed that nicotinic receptor stimulation, especially 7 receptor stimulation, inhibits glutamate toxicity and that PI3K-Akt signal transduction contributes to this effect. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that nicotinic receptor stimulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "especially 7 receptor stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glutamate toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "that PI3K-Akt signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signal Transduction [Cell Function]
   799   C1160185:transduction [Organism Function]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "contributes to this effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.229: In addition, the Bcl-2 family is stimulated downstream of the PI3K-Akt cascade and works as an anti-neuronal death factor. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the Bcl-2 family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "is"

Phrase: "stimulated downstream of the PI3K-Akt cascade"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   810   C1817666:phosphatidylinositol 3-kinase cascade [Molecular Function]
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0522506:Downstream [Spatial Concept]
   742   C0812228:AKT [Gene or Genome]
   742   C1707310:Cascade [Manufactured Object]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   742   C2348046:Phosphatidylinositol [Lipid]

Phrase: "and"

Phrase: "works as an anti-neuronal death factor."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0011065:Death [Organism Function]
   748   C0043227:Work [Occupational Activity]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1306577:Death, NOS [Finding]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   743   C2754100:neuron death [Cell Function]
Processing 00000000.tx.230: It is proposed that PI3K-Akt activation promotes cell survival, and up-regulation of Bcl-2 is one of the major reasons for cell survival (23, 27). 

Phrase: "It"

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that PI3K-Akt activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1879547:Activation [Activity]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "up-regulation of Bcl-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "one of the major reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "for cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.231: Nicotinic receptor stimulation transduces these survival signals besides its role as a transmitter. 

Phrase: "Nicotinic receptor stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "transduces"

Phrase: "these survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "signals besides its role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "as a transmitter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707723:Transmitter [Manufactured Object]
Processing 00000000.tx.232: The sheet conformation of A might influence its function, such as toxicity or modulation of survival signals. 

Phrase: "The sheet conformation of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026377:Conformation [Spatial Concept]

Phrase: "might"

Phrase: "influence"

Phrase: "its function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "such as toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "or"

Phrase: "modulation of survival signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.233: However, in our experiments, nicotine and nicotinic agonists did not influence the sheet conformation (20). 

Phrase: "However,"

Phrase: "in our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "nicotinic agonists"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242948:Nicotinic Agonists [Pharmacologic Substance]
   983 E C3536930:Nicotinic Agonist [Pharmacologic Substance]
   861   C0243192:agonists [Pharmacologic Substance]
   861   C2987634:agonists [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the sheet conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.234: Instead, signal transduction was shown to be important for the protective effect of nicotine. 

Phrase: "Instead,"

Phrase: "signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important for the protective effect of nicotine."
Processing 00000000.tx.235: Our hypothesis for the survival signal transduction is shown in Fig. 

Phrase: "Our hypothesis for the survival signal transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.236: 8. 

Phrase: "8."
Processing 00000000.tx.237: It is not clear from our experiments whether other Src family members besides Fyn are associated with 7 receptors. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear from our experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C2963144:Clear [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "whether"

Phrase: "other Src family members besides Fyn"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0086282:Family Members [Family Group]
   756 E C1611821:Family Member [Intellectual Product]
   753   C0015576:Family [Family Group]
   753   C0680022:members [Population Group]
   753   C1704727:Family [Conceptual Entity]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "associated with 7 receptors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.238: However, a relationship between nicotinic receptors and Fyn was implicated because catecholamine release induced by nicotine is dependent upon the presence of Fyn and extracellular Ca2+, and no other Src member was detected (28). 

Phrase: "However,"

Phrase: "a relationship between nicotinic receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "implicated"

Phrase: "because"

Phrase: "catecholamine release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "induced by nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "is"

Phrase: "dependent upon the presence of Fyn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "extracellular Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "no other Src member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0680022:member [Population Group]
   861   C2698041:Member [Professional or Occupational Group]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.239: In our preliminary data, removal of extracellular Ca2+ suppressed Akt phosphorylation induced by nicotine (data not shown). 

Phrase: "In our preliminary data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "removal of extracellular Ca2+ suppressed Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "induced by nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.240: We showed that an inhibitor of Src tyrosine kinase reduced Akt phosphorylation. 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "an inhibitor of Src tyrosine kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1268567:Tyrosine Kinase Inhibitor [Pharmacologic Substance]
   783   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   783   C3537023:kinase inhibitor [Molecular Function]
   783   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "Akt phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.241: In addition, PI3K and Fyn are physically associated with 7 nicotinic receptors. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PI3K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "physically"

Phrase: "associated with 7 nicotinic receptors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.242: Therefore, nicotinic receptor stimulation might phosphorylate Akt by signal transduction through Fyn to PI3K, and extracellular Ca2+ might contribute to this process. 

Phrase: "Therefore,"

Phrase: "nicotinic receptor stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "might"

Phrase: "phosphorylate"

Phrase: "Akt by signal transduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0812228:AKT [Gene or Genome]

Phrase: "through Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "extracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "might"

Phrase: "contribute to this process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1522240:Process [Phenomenon or Process]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.243: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.244: 8.  

Phrase: "8."
Processing 00000000.tx.245: A schematic model of the neuroprotection induced by 7 nicotinic receptor stimulation. 

Phrase: "A schematic model of the neuroprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "induced by 7 nicotinic receptor stimulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0205263:Induced [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.246: In the brain, nicotinic receptors include several subtypes with differing properties and functions. 

Phrase: "In the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "several subtypes with differing properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:subtypes [Classification]

Phrase: "and"

Phrase: "functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.247: The abundant presence of 7 receptors in the hippocampus, neocortex, and basal ganglia (29), in conjunction with the memory-enhancing activity of selective 7 nicotinic agonists such as DMXB (30), suggests a significant role for 7 receptors in learning and memory. 

Phrase: "The abundant presence of 7 receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "neocortex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "basal ganglia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004781:Basal Ganglia [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "in conjunction with the memory-enhancing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "of selective 7 nicotinic agonists"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0242948:Nicotinic Agonists [Pharmacologic Substance]
   844 E C3536930:Nicotinic Agonist [Pharmacologic Substance]
   812   C0243192:agonists [Pharmacologic Substance]
   812   C2987634:agonists [Pharmacologic Substance]

Phrase: "such as DMXB"

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a significant role for 7 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.248: In addition, the protective action of nicotine is mediated, at least partially, through 7 receptors. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the protective action of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "is"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "at least partially,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "through 7 receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.249: Recently it was reported that A 1-42 binds to 7 receptors (31), and this might inhibit 7 nicotinic receptor-dependent learning and memory. 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to 7 receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "7 nicotinic receptor-dependent learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0013621:learning [Educational Activity]
   804   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.250: The reduction of 7 receptor activation might cause neurons vulnerable to various toxic insults such as glutamate. 

Phrase: "The reduction of 7 receptor activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "vulnerable to various toxic insults"

Phrase: "such as glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.251: In our study, however, the lysate immunoprecipitated with anti-7 antibody did not contain A 1-42 (data not shown). 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "the lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "immunoprecipitated with anti-7 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.252: This might be because the antibody we used was different from that used in the report (31), but we could not prove that enhancement of glutamate toxicity depends upon the reduction of 7 nicotinic receptors. 

Phrase: "This"

Phrase: "might"

Phrase: "be"

Phrase: "because"

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "different from that"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "used in the report"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1273517:used [Finding]
   770   C3273238:Report [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prove"

Phrase: "that enhancement of glutamate toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "depends upon the reduction of 7 nicotinic receptors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C0725813:depend [Medical Device]
Processing 00000000.tx.253: In addition, A 12-28, which suppresses the formation of the 7-A complex (31), did not inhibit the enhanced glutamate toxicity induced by the combined exposure to of A 1-40 and A 1-42 (Fig. 2b). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "A 12-28,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the formation of the 7-A complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the enhanced glutamate toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "induced by the combined exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205195:Combined [Qualitative Concept]
   760   C0205263:Induced [Functional Concept]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "to"

Phrase: "of A 1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0439509:/40 [Temporal Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "A 1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.254: Therefore, it is unlikely that the protective effect of nicotine depends upon the displacement of 7-A binding. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the protective effect of nicotine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "depends upon the displacement of 7-A binding."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0012725:Displacement [Mental Process]
   744   C0012727:Displacement [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C0456080:Displacement [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0725813:depend [Medical Device]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2347509:Displacement [Phenomenon or Process]
Processing 00000000.tx.255: Recently, it was shown that ionotropic receptors have properties similar to metabotropic receptors. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ionotropic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "similar to metabotropic receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.256: AMPA receptors are physically associated with a member of the Src family, Lyn (15). 

Phrase: "AMPA receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0072899:AMPA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1819187:AMPA receptor [Cell Component]
   861   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "physically"

Phrase: "associated with a member of the Src family,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0015576:Family [Family Group]
   744   C0680022:member [Population Group]
   744   C1704727:Family [Conceptual Entity]
   744   C2698041:Member [Professional or Occupational Group]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "Lyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.257: The AMPA receptor activates Lyn, which then activates MAPK. 

Phrase: "The AMPA receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0072899:AMPA Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1819187:AMPA receptor [Cell Component]
   861   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Lyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MAPK."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.258: Through the Lyn-MAPK pathway, AMPA receptors generate intracellular signals and transmit them from the cell surface to the nucleus. 

Phrase: "Through the Lyn-MAPK pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "AMPA receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0072899:AMPA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1819187:AMPA receptor [Cell Component]
   861   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "generate"

Phrase: "intracellular signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "them from the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "to the nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.259: Nicotinic receptors are known to be ionotropic receptors. 

Phrase: "Nicotinic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "ionotropic receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.260: The present study indicated that nicotinic receptors also have metabotropic properties, which contribute to neuronal survival. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that nicotinic receptors also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034830:Nicotinic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "metabotropic properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "which"

Phrase: "contribute to neuronal survival."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1819944:neuron survival [Cell Function]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.261: It is likely, however, that many unrecognized receptor functions still remain. 

Phrase: "It"

Phrase: "is"

Phrase: "likely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "however,"

Phrase: "that"

Phrase: "many unrecognized receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "still"

Phrase: "remain."
Processing 00000000.tx.262: The cholinergic system is affected in dementia-causing diseases, AD among others, and a reduction in the number of nicotinic receptors in these diseases has been reported (32, 33). 

Phrase: "The cholinergic system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0684164:cholinergic system [Biologically Active Substance]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "affected in dementia-causing diseases,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C1314792:disease cause [Functional Concept]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0392760:Affected [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0678227:Causing [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]
   726 E C0015127:cause [Functional Concept]
   726 E C1524003:Cause [Conceptual Entity]

Phrase: "AD among others,"

Phrase: "and"

Phrase: "a reduction in the number of nicotinic receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.263: It is of interest that down-regulation of nicotinic receptors can result in neuronal cell death or neurodegeneration (34). 

Phrase: "It"

Phrase: "is of"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that down-regulation of nicotinic receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0949469:Receptor Down-Regulation [Molecular Function]
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "can"

Phrase: "result in neuronal cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1274040:Result [Functional Concept]
   760   C1306577:Death, NOS [Finding]
   760   C1546471:Result [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2825142:Result [Finding]

Phrase: "or"

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.264: Nicotine might function not only as a cholinergic agonist but also as a neuroprotective agent. 

Phrase: "Nicotine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028040:Nicotine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "might"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "not only as a cholinergic agonist"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0242894:Cholinergic Agonist [Pharmacologic Substance]
   790   C3536927:Cholinergic Agonist [Pharmacologic Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0599668:cholinergic [Functional Concept]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]
   753   C2987634:Agonist [Pharmacologic Substance]

Phrase: "but"

Phrase: "also as a neuroprotective agent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0242912:Neuroprotective Agent [Pharmacologic Substance]
   760   C0450442:Agent [Chemical Viewed Functionally]
   760   C1254351:Agent [Pharmacologic Substance]
   760   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.265: Our present study suggests that nicotinic receptor stimulation could protect neurons from A-enhanced glutamate toxicity. 

Phrase: "Our present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nicotinic receptor stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0034830:Nicotinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "protect"

Phrase: "neurons from A-enhanced glutamate toxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]
Processing 00000000.tx.266: Thus, by an early diagnosis of AD and protective therapy with nicotinic receptor stimulation, we could delay the progress of AD.  

Phrase: "Thus,"

Phrase: "by an early diagnosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596473:Early Diagnosis [Diagnostic Procedure]
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of AD"

Phrase: "and"

Phrase: "protective therapy with nicotinic receptor stimulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]

Phrase: "we"

Phrase: "could"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "the progress of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]
Processing 00000000.tx.267: ACKNOWLEDGEMENT We thank the Taiho Pharmaceutical Co., for providing us with DMXB.  

Phrase: "ACKNOWLEDGEMENT"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Taiho Pharmaceutical Co.,"

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with DMXB."
Processing 00000000.tx.268: FOOTNOTES * This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture and grants from the Ministry of Welfare of Japan, the Smoking Research Foundation, and the Inamori Foundation.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants-in-aid"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0018173:Grants [Quantitative Concept]
   827   C0018896:Aid [Social Behavior]
   827   C0449435:Aid [Manufactured Object]
   827   C3540469:AID [Gene or Genome]
   793 E C1548284:Grant [Idea or Concept]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "and"

Phrase: "Culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "grants from the Ministry of Welfare of Japan,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0018173:Grants [Quantitative Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "the Smoking Research Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   859   C2986512:Research Base [Organization]
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Inamori Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.269: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.270: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.271: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.272: To whom correspondence should be addressed: Dept. of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507,Japan. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Kyoto University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyoto 606-8507,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.273: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.274: 81-75-751-3767; 

Phrase: "81-75-751-3767"

Phrase: ";"
Processing 00000000.tx.275: Fax: 81-75-751-9541; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-75-751-9541"

Phrase: ";"
Processing 00000000.tx.276: E-mail: i53367@sakura.kudpc.kyoto-u.ac.jp. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "i53367@sakura.kudpc.kyoto-u.ac.jp."
Processing 00000000.tx.277: Published, JBC Papers in Press, January 19,2001,DOI 10.1074/jbc.M008035200 2 T. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "January 19,"

Phrase: "2001,"

Phrase: "DOI 10.1074/jbc.M008035200 2 T."
Processing 00000000.tx.278: Kihara, S.

Phrase: "Kihara,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.279: Shimohama, H.Sawada, K.Honda, T.

Phrase: "Shimohama,"

Phrase: "H.Sawada,"

Phrase: "K.Honda,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.280: Nakamizo, H.

Phrase: "Nakamizo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.281: Shibasaki, T.Kume, and A.Akaike, unpublished data.  

Phrase: "Shibasaki,"

Phrase: "T.Kume,"

Phrase: "and"

Phrase: "A.Akaike,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.282: ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.283: A, -amyloid; 

Phrase: "A, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.284: NO, nitric oxide; 

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.285: PI3K, phosphatidylinositol 3-kinase; 

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.286: AMPA, -amino-3-hydroxy-5-methylisoxazole-4-propionic acid; 

Phrase: "AMPA, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "amino-3-hydroxy-5-methylisoxazole-4-propionic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   892   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   892   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0033482:propionic acid [Organic Chemical]
   812   C0072186:Propionic acid [Organic Chemical,Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]
   793   C2945750:propionic [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.287: EMEM, Eagle's minimum essential medium; 

Phrase: "EMEM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "Eagle's minimum essential medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.288: MAP2, microtubule-associated protein 2; 

Phrase: "MAP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417006:MAP2 [Gene or Genome]
  1000   C1424480:MAP2 [Gene or Genome]

Phrase: "microtubule-associated protein 2"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0024773:Microtubule-Associated Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417006:MICROTUBULE-ASSOCIATED PROTEIN 2 [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.289: BTX, -bungarotoxin; 

Phrase: "BTX, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: "bungarotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006385:Bungarotoxin [Hazardous or Poisonous Substance]

Phrase: ";"
Processing 00000000.tx.290: DMXB, 3-(2,4)-dimethoxybenzylidene anabaseine; 

Phrase: "DMXB,"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: ")-"

Phrase: "dimethoxybenzylidene anabaseine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0293641:anabaseine [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.291: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.292: IP, immunoprecipitate(s).  

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.293: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.294: Giannakopoulos, P., Hof, P. 

Phrase: "Giannakopoulos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.295: R., Kovari, E., Vallet, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kovari,"

Phrase: "E.,"

Phrase: "Vallet,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: G., Herrmann, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Herrmann,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.297: R., and Bouras, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bouras,"

Phrase: "C."
Processing 00000000.tx.298: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.299: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.300: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.301: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.302: 55, 1210-1220[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "1210-1220"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.303: Yankner, B. 

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.304: A., Duffy, L. 

Phrase: "A.,"

Phrase: "Duffy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.305: K., and Kirschner, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "D."
Processing 00000000.tx.306: A. 

Phrase: "A."
Processing 00000000.tx.307: (1990) Science 250, 279-282[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 250,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "279-282"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.308: Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.309: Y., Seubert, P., Vigo, P. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.310: C., Lieberburg, I., and Selkoe, D. 

Phrase: "C., Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.313: Tomita, T., Maruyama, K., Saido, T. 

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.314: C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grunberg, J., Haass, C., Iwatsubo, T., and Obata, K. 

Phrase: "C., Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.315: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.316: Natl. 

Phrase: "Natl."
Processing 00000000.tx.317: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.318: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.319: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.320: 94, 2025-2030[Abstract/Free FullText] 5. 

Phrase: "94,"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.321: Guo, Q., Fu, W., Sopher, B. 

Phrase: "Guo,"

Phrase: "Q.,"

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "W.,"

Phrase: "Sopher,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.322: L., Miller, M. 

Phrase: "L., Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0402830:Miller [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: W., Ware, C. 

Phrase: "W., Ware,"

Phrase: "C."
Processing 00000000.tx.324: B., Martin, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.325: M., and Mattson, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.327: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.328: Med. 

Phrase: "Med."
Processing 00000000.tx.329: 5, 101-106[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "101-106"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.330: Tamura, Y., Sato, Y., Akaike, A., and Shiomi, H. 

Phrase: "Tamura,"

Phrase: "Y.,"

Phrase: "Sato,"

Phrase: "Y.,"

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Shiomi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.331: (1992) Brain Res. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.332: 592, 317-325[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "592,"

Phrase: "317-325"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.333: Harris, M. 

Phrase: "Harris,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.334: E., Wang, Y., Pedigo, N. 

Phrase: "E.,"

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Pedigo,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.335: W.J., Hensley, K., Butterfield, D. 

Phrase: "W.J.,"

Phrase: "Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.336: A., and Carney, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.337: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.339: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.340: 67, 277-286[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "67,"

Phrase: "277-286"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.341: Akaike, A., Tamura, Y., Yokota, T., Shimohama, S., and Kimura, J. 

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Tamura,"

Phrase: "Y.,"

Phrase: "Yokota,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kimura,"

Phrase: "J."
Processing 00000000.tx.342: (1994) Brain Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.343: 644, 181-187[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "644,"

Phrase: "181-187"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.344: Shimohama, S., Akaike, A., and Kimura, J. 

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kimura,"

Phrase: "J."
Processing 00000000.tx.345: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.346: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.347: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.348: 777, 356-361[Abstract] 10. 

Phrase: "777,"

Phrase: "356-361"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10."
Processing 00000000.tx.349: Kaneko, S., Maeda, T., Kume, T., Kochiyama, H., Akaike, A., Shimohama, S., and Kimura, J. 

Phrase: "Kaneko,"

Phrase: "S."

Phrase: ","

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kume,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kochiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kimura,"

Phrase: "J."
Processing 00000000.tx.350: (1997) Brain Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.351: 765, 135-140[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "765,"

Phrase: "135-140"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.352: Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., and Akaike, A. 

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Sawada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kimura,"

Phrase: "J.,"

Phrase: "Kume,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kochiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Akaike,"

Phrase: "A."
Processing 00000000.tx.353: (1997) Ann. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.354: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.355: 42, 159-163[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "42,"

Phrase: "159-163"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.356: Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T., and Akaike, A. 

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Urushitani,"

Phrase: "M."

Phrase: ","

Phrase: "Sawada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kimura,"

Phrase: "J.,"

Phrase: "Kume,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Akaike,"

Phrase: "A."
Processing 00000000.tx.357: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.358: 792, 331-334[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "792,"

Phrase: "331-334"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.359: del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. 

Phrase: "del Peso,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gonzalez-Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442999:Garcia [Intellectual Product]
   861   C1621797:Garcia [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Herrera,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Nunez,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.360: (1997) Science 278, 687-689[Abstract/Free FullText] 14. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 278,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "687-689"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.361: Perkinton, M. 

Phrase: "Perkinton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: S., Sihra, T. 

Phrase: "S."

Phrase: ","

Phrase: "Sihra,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.363: S., and Williams, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: J. 

Phrase: "J."
Processing 00000000.tx.365: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.366: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.367: 19, 5861-5874[Abstract/Free FullText] 15. 

Phrase: "19,"

Phrase: "5861-5874"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.368: Hayashi, T., Umemori, H., Mishina, M., and Yamamoto, T. 

Phrase: "Hayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Umemori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mishina,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.369: (1999) Nature 397, 72-76[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 397,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "72-76"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.370: Shimohama, S., Ogawa, N., Tamura, Y., Akaike, A., Tsukahara, T., Iwata, H., and Kimura, J. 

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tamura,"

Phrase: "Y.,"

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Tsukahara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kimura,"

Phrase: "J."
Processing 00000000.tx.371: (1993) Brain Res. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.372: 632, 296-302[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "632,"

Phrase: "296-302"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.373: Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., and Shimohama, S. 

Phrase: "Sawada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ibi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325469:ibi [Bird]

Phrase: "M."

Phrase: ","

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Urushitani,"

Phrase: "M."

Phrase: ","

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Kimura,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Shimohama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.375: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.376: 44, 110-119[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "44,"

Phrase: "110-119"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.377: Kume, T., Kochiyama, H., Kaneko, S., Maeda, T., Kaneko, S., Akaike, A., Shimohama, S., Kihara, T., Kimura, J., Wada, K., and Koizumi, S. 

Phrase: "Kume,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kochiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kaneko,"

Phrase: "S."

Phrase: ","

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kaneko,"

Phrase: "S."

Phrase: ","

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kimura,"

Phrase: "J.,"

Phrase: "Wada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Koizumi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: (1997) Brain Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.379: 756, 200-204[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "756,"

Phrase: "200-204"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.380: Jensen, M., Schroder, J., Blomberg, M., Engvall, B., Pantel, J., Ida, N., Basun, H., Wahlund, L. 

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Schroder,"

Phrase: "J.,"

Phrase: "Blomberg,"

Phrase: "M."

Phrase: ","

Phrase: "Engvall,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pantel,"

Phrase: "J.,"

Phrase: "Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Basun,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wahlund,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.381: O., Werle, E., Jauss, M., Beyreuther, K., Lannfelt, L., and Hartmann, T. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Werle,"

Phrase: "E.,"

Phrase: "Jauss,"

Phrase: "M."

Phrase: ","

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hartmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.382: (1999) Ann. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.383: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.384: 45, 504-511[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "45,"

Phrase: "504-511"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.385: Kihara, T., Shimohama, S., and Akaike, A. 

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Akaike,"

Phrase: "A."
Processing 00000000.tx.386: (1999) Jpn. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Jpn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:JPN [Geographic Area]
Processing 00000000.tx.387: J.

Phrase: "J."
Processing 00000000.tx.388: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.389: 79, 393-396[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "79,"

Phrase: "393-396"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.390: Hunter, B. 

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.391: E., de Fiebre, C. 

Phrase: "E.,"

Phrase: "de Fiebre,"

Phrase: "C."
Processing 00000000.tx.392: M., Papke, R. 

Phrase: "M."

Phrase: ","

Phrase: "Papke,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.393: L., Kem, W. 

Phrase: "L., Kem,"

Phrase: "W."
Processing 00000000.tx.394: R., and Meyer, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Meyer,"

Phrase: "E."
Processing 00000000.tx.395: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.396: (1994) Neurosci. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.397: Lett. 

Phrase: "Lett."
Processing 00000000.tx.398: 168, 130-134[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "168,"

Phrase: "130-134"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.399: Zhong, L. 

Phrase: "Zhong,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.400: T., Kane, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kane,"

Phrase: "D."
Processing 00000000.tx.401: J., and Bredesen, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Bredesen,"

Phrase: "D."
Processing 00000000.tx.402: E. 

Phrase: "E."
Processing 00000000.tx.403: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.404: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.405: 19, 353-355[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "19,"

Phrase: "353-355"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.406: Matsuzaki, H., Tamatani, M., Mitsuda, N., Namikawa, K., Kiyama, H., Miyake, S., and Tohyama, M. 

Phrase: "Matsuzaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tamatani,"

Phrase: "M."

Phrase: ","

Phrase: "Mitsuda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Namikawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyake,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Tohyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.408: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.409: 73, 2037-2046[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "73,"

Phrase: "2037-2046"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.410: O'Mahony, S., Harkany, T., Rensink, A. 

Phrase: "O'Mahony,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "S."

Phrase: ","

Phrase: "Harkany,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rensink,"

Phrase: "A."
Processing 00000000.tx.411: A., Abraham, I., De Jong, G. 

Phrase: "A.,"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "De Jong,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.412: I., Varga, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Varga,"

Phrase: "J."
Processing 00000000.tx.413: L., Zarandi, M., Penke, B., Nyakas, C., Luiten, P. 

Phrase: "L., Zarandi,"

Phrase: "M."

Phrase: ","

Phrase: "Penke,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Nyakas,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Luiten,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.414: G., and Leonard, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Leonard,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.415: E. 

Phrase: "E."
Processing 00000000.tx.416: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.417: Bull. 

Phrase: "Bull."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007452:Bull [Mammal]
Processing 00000000.tx.418: 45, 405-411[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "45,"

Phrase: "405-411"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.419: Dornan, W. 

Phrase: "Dornan,"

Phrase: "W."
Processing 00000000.tx.420: A., Kang, D. 

Phrase: "A.,"

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.421: E., McCampbell, A., and Kang, E. 

Phrase: "E.,"

Phrase: "McCampbell,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kang,"

Phrase: "E."
Processing 00000000.tx.422: E. 

Phrase: "E."
Processing 00000000.tx.423: (1993) Neuroreport 5, 165-168[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuroreport 5,"

Phrase: "165-168"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.424: Morimoto, K., Yoshimi, K., Tonohiro, T., Yamada, N., Oda, T., and Kaneko, I. 

Phrase: "Morimoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tonohiro,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kaneko,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.425: (1998) Neuroscience 84, 479-487[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuroscience 84,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "479-487"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.426: Eves, E. 

Phrase: "Eves,"

Phrase: "E."
Processing 00000000.tx.427: M., Xiong, W., Bellacosa, A., Kennedy, S. 

Phrase: "M."

Phrase: ","

Phrase: "Xiong,"

Phrase: "W.,"

Phrase: "Bellacosa,"

Phrase: "A.,"

Phrase: "Kennedy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.428: G., Tsichlis, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tsichlis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: N., Rosner, M. 

Phrase: "N., Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: R., and Hay, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440666:Hay [Immunologic Factor]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.431: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.432: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.433: Biol. 

Phrase: "Biol."
Processing 00000000.tx.434: 18, 2143-2152[Abstract/Free FullText] 28. 

Phrase: "18,"

Phrase: "2143-2152"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.435: Allen, C. 

Phrase: "Allen,"

Phrase: "C."
Processing 00000000.tx.436: M., Ely, C. 

Phrase: "M."

Phrase: ","

Phrase: "Ely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551591:Ely [Population Group]

Phrase: "C."
Processing 00000000.tx.437: M., Juaneza, M. 

Phrase: "M."

Phrase: ","

Phrase: "Juaneza,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: A., and Parsons, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Parsons,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: J. 

Phrase: "J."
Processing 00000000.tx.440: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.442: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.443: 44, 421-429[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "44,"

Phrase: "421-429"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.444: Clarke, P. 

Phrase: "Clarke,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: B., Schwartz, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schwartz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.446: D., Paul, S. 

Phrase: "D."

Phrase: ","

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: M., Pert, C. 

Phrase: "M."

Phrase: ","

Phrase: "Pert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599890:PERT [Hormone]

Phrase: "C."
Processing 00000000.tx.448: B., and Pert, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pert, A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.449: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.450: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.451: 5, 1307-1315[Abstract] 30. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1307-1315"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 30."
Processing 00000000.tx.452: Meyer, E. 

Phrase: "Meyer,"

Phrase: "E."
Processing 00000000.tx.453: M., Tay, E. 

Phrase: "M."

Phrase: ","

Phrase: "Tay,"

Phrase: "E."
Processing 00000000.tx.454: T., Papke, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Papke,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.455: L., Meyers, C., Huang, G. 

Phrase: "L., Meyers,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.456: L., and de Fiebre, C. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "de Fiebre,"

Phrase: "C."
Processing 00000000.tx.457: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.458: (1997) Brain Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.459: 768, 49-56[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "768,"

Phrase: "49-56"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.460: Wang, H. 

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: Y., Lee, D. 

Phrase: "Y.,"

Phrase: "Lee,"

Phrase: "D."
Processing 00000000.tx.462: H., D'Andrea, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "D'"

Phrase: "Andrea,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: R., Peterson, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Peterson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.464: A., Shank, R. 

Phrase: "A.,"

Phrase: "Shank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444675:Shank [Body Location or Region]
  1000   C1422551:SHANK [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: P., and Reitz, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Reitz,"

Phrase: "A."
Processing 00000000.tx.466: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.467: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.468: Biol. 

Phrase: "Biol."
Processing 00000000.tx.469: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.470: 275, 5626-5632[Abstract/Free FullText] 32. 

Phrase: "275,"

Phrase: "5626-5632"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.471: Shimohama, S., Taniguchi, T., Fujiwara, M., and Kameyama, M. 

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Taniguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujiwara,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kameyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.473: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.474: 46, 288-293[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "46,"

Phrase: "288-293"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.475: Whitehouse, P. 

Phrase: "Whitehouse,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.476: J., and Kalaria, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Kalaria,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.478: (1995) Alzheimer Dis. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Alzheimer Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.479: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.480: Disord. 

Phrase: "Disord."
Processing 00000000.tx.481: 9, 3-5[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "9,"

Phrase: "3-5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.482: Zoli, M., Picciotto, M. 

Phrase: "Zoli,"

Phrase: "M."

Phrase: ","

Phrase: "Picciotto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.483: R., Ferrari, R., Cocchi, D., and Changeux, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ferrari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cocchi,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Changeux,"

Phrase: "J."
Processing 00000000.tx.484: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.486: 18, 1235-1244[Abstract/Free FullText] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "18,"

Phrase: "1235-1244"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

